Trial Profile
A retrospective study to evaluate the effect of treatment with Boceprevir in HIV positive patients with hepatitis C genotype 1 at high risk for failure to treatment with pegylated interferon/Ribavirin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2017
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon alfa-2b/ribavirin
- Indications HIV infections
- Focus Therapeutic Use
- 25 May 2017 New trial record